Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACER3	"APHC, FLJ11238, PHCA"	ENSG00000078124	"Alkaline ceramidase 3"	Q9NUN7	11	76860867-77026797	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA070087	Approved					NA	NA					"HPA070087: AB_2732147"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (7.13e-2)"	"unprognostic (2.35e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.68e-3)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.97e-2)"	18.3	5.9	11.8	8.6	19.8	7.1	7.8	7.9	15.2	10.5	10.8	29.5	1.5	12.0	7.0	7.1	9.8	5.4	6.3	5.3	14.7	11.0	9.1	4.9	11.3	8.2	27.3	7.2	4.0	4.6	8.3	3.6	31.6	21.8	8.3	10.0	6.0	6.3	5.0	2.7	6.1	8.1	7.2	22.0	8.7	7.2	9.3	24.6	1.3	6.0	6.5	6.7	5.4	6.5	1.6	4.7	3.9	5.0	0.6	2.2	1.4	4.9	5.9	4.9	5.9	22.0	10.5	3.2	7.3	7.5	6.2	6.7	4.1	5.5	4.6	5.3	5.6	7.1	8.8	6.6	7.8	7.5	5.6	2.2	7.2	4.0	2.8	6.1	6.5	12.5	5.3	3.9	7.3	8.2	3.6	10.5	4.0	4.0	2.3	6.9	4.7	0.5	5.0	2.5	14.0	5.8	2.9	16.5	3.1	5.2	5.2	1.7	4.3	8.6	10.0	2.7	3.5	7.2	3.9	13.7	6.1	4.6	18.4	5.9	2.0	4.2	6.4	3.9	3.7	7.2	0.6	5.0	3.9	1.2	4.5	1.4	1.6	0.9	1.5	4.7	1.0	0.7	1.0	1.8	0.6	2.8	2.5	2.2	1.4	11.8	19.8	7.9	14.4	14.7	11.0	27.3	7.2	21.8	24.6	38.7	44.4	9.7	19.0	28.3	17.8	6.0	10.2	16.0	36.4	8.7	9.8	10.6	6.6	13.8	46.3	25.2	28.7	0.0	15.4	6.2	15.6	13.3	79.9	8.6	38.9	41.3	2.4	30.1	55.7	26.2	18.7	52.0	16.9	19.8	22.5	12.0	14.1	31.5	24.4	11.0	9.4	6.5	21.7	73.8	17.9	14.6	22.4	10.7	16.2	19.2
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650659	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 72.2;kidney: 28.9"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 163.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;monocytes: 21.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.1;CAPAN-2: 9.5;Daudi: 34.5;OE19: 9.6;RPMI-8226: 6.0"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA					"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	3.4	1.8	5.5	0.6	0.5	0.8	7.8	5.5	13.0	15.3	0.2	38.2	0.3	2.1	0.7	0.4	6.1	0.1	3.1	2.9	28.9	18.3	0.2	3.1	4.6	5.1	0.1	11.2	0.0	0.3	0.1	7.1	0.4	2.2	0.3	1.2	0.2	0.1	0.1	72.2	0.1	5.2	0.9	5.9	0.1	2.8	0.7	0.2	0.0	4.2	0.2	0.2	1.1	5.9	0.0	21.1	2.3	0.9	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.1	9.5	34.5	0.4	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	1.2	1.5	0.0	9.6	0.0	1.1	0.0	6.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.3	0.0	0.5	0.0	0.1	4.9	0.5	1.0	0.2	0.1	2.6	1.1	0.9	0.6	0.0	2.3	21.1	5.9	0.0	1.2	3.4	5.5	0.8	7.8	3.1	2.9	4.6	5.1	7.1	2.8	0.0	1.7	6.3	0.1	0.0	0.0	0.4	10.2	0.0	1.2	21.0	0.0	0.2	26.6	3.5	0.0	0.0	11.8	0.0	9.0	0.2	0.0	0.6	0.0	17.9	1.7	0.0	1.2	0.0	0.3	0.0	0.0	0.9	5.0	0.0	25.1	0.0	6.8	5.9	0.0	163.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	6.6	0.8
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 39.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9"	"Cell line enhanced"	"Detected in many"		"A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038525	Uncertain					NA	NA					"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	9.1	9.8	1.8	5.0	2.5	21.4	2.4	1.3	2.3	6.2	7.8	4.2	1.1	11.8	4.0	7.0	4.0	21.0	13.7	3.1	2.6	2.4	9.3	5.1	28.5	14.3	4.3	1.4	6.6	12.9	0.0	3.8	13.4	3.8	4.6	3.1	7.8	5.7	2.0	2.0	1.8	21.4	4.2	5.6	11.7	10.4	2.9	1.9	0.7	1.7	1.5	3.3	7.6	3.8	0.1	17.6	39.8	32.9	2.9	0.1	9.8	3.3	45.0	0.3	0.9	3.0	9.6	8.1	4.6	7.6	3.3	1.6	1.6	46.3	0.2	8.2	10.6	4.7	3.8	0.1	0.6	0.8	0.1	0.3	0.4	18.1	3.9	19.1	2.6	0.1	7.0	2.0	1.6	4.5	7.5	0.1	0.2	0.1	8.2	5.3	2.7	0.2	2.5	0.3	22.4	2.7	1.0	1.8	24.7	5.4	0.4	0.5	0.2	10.6	8.9	4.4	0.2	10.3	5.8	5.1	4.8	6.7	23.1	1.5	0.1	0.8	0.0	27.3	7.3	2.2	11.8	23.0	39.8	0.0	32.9	0.1	0.1	0.0	0.0	17.6	0.1	0.0	0.0	6.9	2.9	29.1	1.8	0.0	9.8	1.8	2.5	1.3	2.3	2.6	2.4	4.3	1.4	3.8	1.9	107.2	53.7	0.9	2.6	1.9	0.5	2.4	17.8	265.0	76.2	5.2	0.0	0.7	0.0	4.9	18.4	1.9	11.7	0.0	2.2	6.7	8.2	2.5	23.3	2.0	31.5	3.2	2.4	1.3	54.8	7.6	1.7	31.3	3.3	8.2	10.0	2.0	11.4	7.0	1.4	20.0	0.4	0.0	4.2	0.2	0.2	0.9	0.6	0.0	10.0	4.4
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MCF7: 31.6;SK-BR-3: 32.7"					"Not detected"	"Not detected"			HPA045132	Approved					NA	NA					"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	2.6	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	32.7	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.9	0.0	1.5	1.4	0.0	0.3	0.0	0.0	0.0	5.2	0.0	8.5	1.7	0.3	0.0	0.0	0.0	0.0	0.2	8.0	0.4	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.2	0.0	0.0	6.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943293-95968716	"Enzymes, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 99.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 125.2"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		410000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.1	5.7	0.5	2.4	0.8	2.0	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99.0	1.3	1.4	0.5	0.4	0.7	1.1	0.0	1.2	0.6	1.0	0.7	0.0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.5	4.3	0.3	2.8	0.1	0.0	4.4	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0.0	1.1	3.7	0.1	0.0	0.1	6.8	0.7	1.9	3.0	3.8	0.0	2.5	21.5	0.0	0.1	0.3	0.0	0.1	0.1	1.7	1.3	26.6	0.0	3.0	1.6	4.8	2.0	0.7	1.0	3.5	0.1	2.2	0.0	1.8	2.2	3.2	17.8	20.0	2.3	0.0	2.1	3.6	0.0	2.8	9.7	3.5	2.4	21.5	25.2	2.7	1.9	5.2	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1.0	1.0	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1.0	0.5	0.0	0.3	2.2	0.2	0.3	0.0	0.4	0.0	0.0	1.2	3.5	0.0	0.5	3.3	0.1	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.0	0.0	125.2	4.1	1.6	1.7	11.1	3.7	0.0	0.3	1.1	3.3	0.0	0.0	1.9	0.3	0.0	0.0	23.2	0.0	0.0	0.0	1.2	1.9	0.3	0.2	2.9	0.0	0.1
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell type enhanced"	"Detected in many"	19	"Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4"					"Not detected"	"Not detected"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.4	0.0	2.2	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	5.0	0.2	1.5	0.0	0.0	0.0	6.0	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.3	0.6	21.4	0.5	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	258.2	0.0	1.1	13.3	0.0	5.7	0.0	648.3	0.0	3.0	3.0	0.2	0.9	5.7	0.0	2.8	0.0	41.6	0.0	0.0	8.4	0.0	1.3	0.0	115.4	108.6	0.0	2.2	375.2	0.0	73.1	0.0	0.0	0.1	2.8	0.7	0.1	2.9	0.0	80.4	0.3
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase, copper containing 2"	O75106	17	42844600-42850707	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 133.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 28.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	11.6	1.2	0.9	1.3	3.2	1.8	3.1	3.2	1.6	1.5	1.1	0.9	0.9	0.6	1.5	1.2	1.0	1.5	1.5	1.3	1.2	1.8	0.9	3.6	2.2	1.0	0.9	0.9	1.0	1.2	0.8	2.1	0.9	0.9	1.3	0.5	133.5	1.2	1.2	1.4	1.2	1.0	1.3	1.0	1.7	0.7	6.5	0.9	1.0	1.0	0.9	1.2	1.6	0.9	0.1	0.0	4.0	0.0	0.0	0.6	0.0	0.2	2.8	0.6	3.1	14.3	1.4	7.4	0.9	0.9	2.0	2.8	2.2	0.3	1.1	1.4	0.3	0.9	1.2	2.7	0.7	4.1	2.3	7.3	0.4	1.3	2.2	0.9	0.4	2.8	2.2	2.5	1.9	2.9	0.4	0.5	3.8	0.7	2.6	0.6	0.3	0.6	1.1	1.1	0.3	0.9	1.4	2.9	2.3	0.4	4.4	1.0	0.6	0.1	1.0	4.0	6.0	0.5	0.2	0.5	1.9	4.1	2.5	1.2	5.7	5.6	1.1	0.5	2.6	1.0	0.0	0.0	0.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	3.2	1.6	1.2	1.8	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.5	0.9	0.2	0.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.4	28.8	0.7	0.0	0.0	0.3	0.1	0.2	0.7	0.0	0.8	0.1	0.0	0.0	0.6	0.8	3.3	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	0.6	0.0	0.9	2.1	2.7	1.4	0.0	0.0	0.0	0.5
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
ARID4B	"BCAA, BRCAA1, RBP1L1, SAP180"	ENSG00000054267	"AT-rich interaction domain 4B"	Q4LE39	1	235131634-235328219	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027205, HPA027333"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027205: , HPA027333: AB_1845013"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.84e-3)"	15.3	13.8	14.9	19.0	22.5	34.1	15.9	32.8	17.6	19.7	13.4	19.2	18.2	9.1	18.7	18.1	12.0	15.0	15.2	10.6	15.2	14.5	13.1	14.0	15.5	22.3	26.9	13.9	21.8	16.8	23.8	25.7	14.7	20.3	17.9	10.7	12.0	16.7	17.0	12.3	12.3	14.2	14.6	19.8	19.8	14.7	19.5	23.4	33.7	20.2	8.2	18.9	18.2	18.6	17.1	11.7	35.9	11.8	16.6	17.0	6.0	12.2	9.2	16.2	12.5	11.9	12.5	13.3	14.0	12.3	9.7	9.5	9.5	13.1	14.4	16.3	10.5	6.9	10.9	13.1	5.9	14.1	18.5	14.2	11.6	11.1	7.9	9.1	12.4	17.1	8.4	8.0	11.9	10.2	12.7	13.1	9.2	15.0	20.7	9.1	5.5	18.5	11.3	14.8	8.8	6.1	6.9	11.5	12.0	10.6	10.3	13.2	18.3	17.8	14.8	13.8	4.9	15.6	20.1	18.0	12.0	9.1	14.6	13.6	20.2	16.0	14.4	8.2	9.1	16.0	24.6	7.1	19.5	16.1	7.6	14.7	15.6	17.0	13.7	6.8	17.1	16.9	14.4	35.9	16.6	11.8	11.7	13.6	6.0	14.9	22.5	32.8	17.6	15.2	14.5	26.9	13.9	20.3	23.4	95.3	99.9	54.7	68.9	110.4	111.2	62.2	35.7	91.0	101.2	29.6	113.9	55.7	16.6	62.0	329.6	108.9	41.9	46.7	41.8	58.1	114.7	81.5	105.3	23.1	39.4	106.5	86.4	65.7	52.4	349.2	93.7	99.4	79.2	108.2	45.8	77.7	57.3	49.9	72.9	15.0	150.5	45.3	129.6	212.6	167.8	93.1	131.0	129.6	39.6	111.5
COX10		ENSG00000006695	"COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor"	Q12887	17	14069496-14208677	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.9"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 89.2;Late spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.32e-6)"	"prognostic favorable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	5.5	6.9	5.3	5.7	6.5	7.0	5.4	6.5	7.2	4.4	11.8	4.1	2.9	9.7	5.1	3.6	9.4	4.8	3.5	18.9	5.8	3.8	10.0	9.3	5.2	8.4	4.5	2.8	4.9	9.6	7.2	6.4	6.6	5.7	5.2	10.1	5.5	6.7	4.8	34.9	6.0	10.9	7.2	4.0	4.6	7.7	15.5	4.9	5.9	5.2	9.6	7.4	7.2	5.8	11.9	13.6	4.0	14.1	8.8	17.5	9.8	7.3	14.1	5.9	8.4	5.9	5.4	13.3	8.9	6.2	16.3	11.3	12.3	5.4	17.3	7.1	9.0	5.6	14.1	11.9	11.5	13.1	9.3	12.0	10.3	11.3	13.6	10.3	10.6	9.7	7.7	14.5	10.2	13.0	6.5	8.6	12.3	13.9	5.9	7.2	9.1	9.0	7.0	8.9	27.6	7.3	7.6	19.9	12.2	10.2	13.8	4.4	7.4	9.2	12.3	11.0	29.1	6.9	6.0	7.0	7.1	6.0	7.2	11.2	7.2	10.1	7.8	10.7	11.0	8.8	3.0	10.6	4.0	9.9	14.1	10.4	11.9	11.6	10.3	13.6	8.2	12.6	11.9	1.2	8.8	11.9	4.6	17.5	9.8	5.3	6.5	6.5	7.2	5.8	3.8	4.5	2.8	5.7	4.9	0.0	14.3	5.2	7.2	8.7	8.0	89.2	7.6	5.3	4.5	10.4	9.8	16.5	34.9	8.0	33.1	4.9	19.0	0.0	7.5	14.8	5.1	7.4	4.7	8.9	9.4	0.0	12.1	4.9	3.8	61.2	2.0	5.4	5.0	4.6	14.2	2.8	8.6	11.0	6.3	11.4	11.6	0.0	5.1	14.6	15.9	9.2	13.5	5.3	15.1	11.8
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		380000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.4	0.0	0.0	0.0	0.2	0.4	0.0	43.6	45.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5	0.0	9.8	0.8	0.0	0.0	81.1	0.4	5.1	0.0	1.2	3.5	39.3	0.0	21.6	0.0	3.6	0.0	72.8	0.0	0.7	0.1	0.0	0.4	0.0	58.7	0.1	3.2	394.4	1.3	1.3	4.3	0.0	0.0	0.0	0.0	30.4	24.1	0.2	26.6	0.0	366.2	456.4	0.0	0.0	3.6	0.4	0.0	0.1	0.0	46.0	0.0
DHDDS	"DS, FLJ13102, HDS, RP59"	ENSG00000117682	"Dehydrodolichyl diphosphate synthase subunit"	Q86SQ9	1	26432282-26471294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Transferase	"Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 241.5;Rod photoreceptor cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026721, HPA026727"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA026721: AB_1847643, HPA026727: AB_1847644"	"unprognostic (1.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (9.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.95e-1)"	31.8	14.4	11.2	10.8	15.9	6.4	15.0	45.9	18.8	10.4	23.1	12.5	8.3	12.2	15.4	21.9	18.9	9.2	10.9	14.8	9.7	10.7	16.2	15.3	9.5	10.3	12.1	15.8	9.8	14.7	23.2	15.5	13.1	20.6	9.6	23.9	22.0	56.9	9.1	10.3	13.1	12.2	11.3	7.6	10.5	14.2	12.9	8.9	9.7	12.1	11.1	16.9	10.6	9.8	11.1	11.2	11.8	19.5	8.1	11.6	8.2	14.9	12.2	8.1	11.1	16.8	14.1	14.0	25.6	16.0	19.8	19.8	18.8	16.5	16.9	15.7	23.9	14.5	10.9	10.9	20.0	19.0	10.3	5.8	16.8	30.3	13.8	15.8	18.3	24.8	19.3	11.9	27.3	15.4	13.3	24.9	11.1	12.0	18.6	18.1	10.2	9.3	7.7	12.8	21.0	16.4	11.2	14.4	14.4	10.7	14.1	11.4	9.1	17.2	19.0	11.3	11.7	14.3	10.3	31.7	13.8	13.4	25.9	14.6	22.7	30.4	18.2	21.7	23.0	13.4	6.5	13.4	7.1	11.6	19.5	8.4	11.1	7.7	7.5	11.2	9.3	6.5	9.0	11.8	8.1	18.0	9.1	7.3	8.2	11.2	15.9	45.9	18.8	9.7	10.7	12.1	15.8	20.6	8.9	8.9	5.6	17.5	7.9	4.0	31.4	13.7	12.7	8.1	10.3	14.0	241.5	15.5	10.0	17.0	55.9	9.0	44.5	0.0	12.6	19.4	8.2	11.0	18.5	11.5	21.3	14.3	20.1	11.1	7.3	16.4	9.8	9.7	10.1	48.7	32.2	15.3	14.8	42.1	7.1	20.3	101.1	0.0	10.3	9.3	13.5	4.4	21.3	10.0	14.0	11.1
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363397-43368074	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	21.2	15.6	16.2	15.3	25.3	18.3	24.1	6.8	32.5	16.1	23.6	101.5	11.7	20.7	14.1	13.0	46.6	15.1	17.3	11.5	30.3	18.3	26.6	23.8	22.9	22.7	51.4	14.1	9.3	18.3	16.7	8.4	20.9	45.6	21.6	20.1	8.6	20.6	21.6	6.8	54.0	21.7	20.7	99.5	17.2	22.8	8.4	37.2	7.2	23.9	15.6	21.7	20.4	22.6	30.9	61.1	46.9	54.8	30.5	32.3	48.8	23.8	26.9	5.2	10.3	35.6	33.5	16.3	28.3	35.7	36.1	29.1	23.8	41.9	16.5	22.0	44.3	31.2	27.5	18.4	34.8	22.2	21.2	12.4	21.4	18.6	17.2	30.9	18.4	22.9	25.6	39.6	42.6	47.1	27.1	36.1	6.5	14.8	12.6	41.3	17.6	4.3	15.5	7.6	31.1	27.9	9.7	13.9	20.1	45.5	29.1	6.4	6.7	16.7	59.7	23.8	16.2	28.1	18.4	29.8	30.6	19.4	37.0	35.8	6.3	6.8	7.9	29.8	18.9	27.5	29.0	54.8	46.9	32.3	50.6	28.6	30.9	30.7	31.4	61.1	25.5	20.1	28.1	38.2	30.5	48.1	42.9	31.4	48.8	16.2	25.3	6.8	32.5	30.3	18.3	51.4	14.1	45.6	37.2	17.9	8.4	18.1	20.4	13.9	5.4	3.6	45.9	5.3	7.9	38.4	9.8	79.2	6.6	86.7	2.5	28.7	74.3	70.0	86.6	103.3	20.2	33.0	20.7	13.7	66.2	3.2	18.4	23.4	47.0	3.4	18.7	37.1	11.8	129.8	30.5	12.4	99.9	40.7	24.1	21.3	8.4	19.4	15.3	6.7	8.6	27.0	80.2	24.6	36.9	43.7
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.2	0.0	0.0	0.0	6.4	0.2	0.5	9.9	17.0	0.0	0.0	0.0	0.0	0.6	17.5	0.0	11.7	0.0	16.4	0.0	10.1	0.1	0.2	12.5	0.5	0.2	2.7	0.1	0.0	7.6	0.0	0.6	0.0	0.5	0.6	0.0	0.2	0.0	6.4	0.1	2.1	0.0	9.6	8.9	17.8	0.0	0.0	0.1	4.5	5.1	0.0	0.0	4.1	9.5	2.0	5.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	5.1	0.0	0.0	0.0	27.5	1.6	0.0	4.8	8.6	0.7	0.0	0.0	0.8	17.8	7.2	2.1	0.0	13.2	1.1	0.0	0.0	0.0	0.0	12.4	0.9	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.4	0.0	10.2	19.4	0.3	12.1	7.9	0.0	1.4	0.0	0.0	0.0
ELOVL3	CIG-30	ENSG00000119915	"ELOVL fatty acid elongase 3"	Q9HB03	10	102226328-102229589	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 24.6"	"Cell type enhanced"	"Detected in some"	11	"Ito cells: 1.3;Kupffer cells: 2.4;Smooth muscle cells: 2.0;Spermatogonia: 2.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.6;monocytes: 9.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.3;ASC TERT1: 8.3;HSkMC: 12.2;NB-4: 9.4;SiHa: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036236	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA036236: AB_10601550"	"unprognostic (1.52e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (6.25e-5)"	"unprognostic (8.23e-3)"	"unprognostic (9.82e-2)"	"unprognostic (2.17e-4)"	"unprognostic (4.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.66e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.79e-1)"	6.3	1.1	1.2	2.1	2.4	3.6	7.3	0.4	0.9	0.2	0.2	0.0	0.0	0.0	0.9	0.3	0.3	0.3	2.5	2.5	0.6	0.2	0.5	0.2	1.8	0.1	0.7	0.0	0.2	0.2	0.0	1.8	2.4	1.1	0.3	0.2	1.6	3.4	1.7	1.7	24.6	0.3	0.0	0.2	0.8	0.2	6.8	0.0	0.0	0.2	2.8	0.0	0.6	2.6	0.0	2.6	0.5	9.4	0.0	0.0	1.9	2.6	0.2	0.1	6.6	8.3	8.3	2.4	0.1	0.2	0.3	0.4	0.4	2.5	0.0	0.3	0.0	0.0	0.0	5.0	0.1	0.4	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.1	12.2	1.4	3.0	0.0	0.0	0.0	0.8	0.1	3.0	0.7	0.0	0.0	9.4	0.1	0.9	0.9	0.0	4.3	0.0	1.7	0.0	0.0	0.3	18.9	0.8	0.6	0.5	6.9	2.2	0.0	1.3	0.0	0.3	0.2	0.4	5.8	0.0	3.0	5.4	0.0	0.0	9.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.0	6.6	0.0	0.0	1.9	1.2	2.4	0.4	0.9	0.6	0.2	0.7	0.0	1.1	0.0	0.0	0.6	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.0	0.0	1.3	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 278.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Cell line enhanced"	"Detected in many"		"JURKAT: 25.2;MOLT-4: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.5	6.7	7.4	5.6	5.4	1.0	3.4	3.8	2.9	6.4	0.9	0.0	0.0	0.6	4.7	12.1	0.7	8.6	4.8	2.2	0.0	11.2	0.2	1.4	0.0	5.2	2.6	1.0	4.4	1.8	3.0	3.1	4.2	4.8	25.2	0.0	0.0	6.1	1.1	19.2	0.0	6.4	0.0	3.5	0.0	9.6	0.0	0.1	0.0	8.9	2.6	3.7	5.9	1.0	4.8	2.3	0.2	0.4	1.3	2.6	2.0	2.6	4.5	8.9	0.0	3.1	0.0	2.0	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3	0.0	0.0	0.0	2.3	10.1	47.3	0.4	0.0	0.0	4.5	0.0	139.4	0.8	0.0	0.1	4.5	0.8	0.0	0.0	0.0	1.6	3.2	2.0	0.0	0.0	0.2	39.7	8.5	0.0	0.0	1.8	1.1	0.0	3.3	0.0	0.0	35.8	0.0	0.0	3.2	2.3	278.2	0.0	5.3	13.5	7.8	33.1	0.8	0.5	0.0	0.7
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.9"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 35.3;Hepatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 5.6;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA					"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	7.6	9.8	7.7	7.9	9.4	3.7	7.9	10.9	12.3	4.0	14.5	8.6	0.9	11.8	3.4	2.7	16.6	2.9	11.1	8.1	6.6	5.9	6.4	43.9	3.3	2.2	7.5	9.4	2.0	2.5	10.6	7.1	2.6	15.7	3.0	14.1	4.3	6.9	3.2	1.4	12.3	10.2	5.7	20.0	1.9	16.9	1.3	7.3	1.1	2.3	7.9	4.0	6.0	5.0	0.1	0.0	0.2	0.1	5.6	4.9	0.8	13.4	8.0	29.3	7.3	19.7	20.7	15.0	9.4	4.6	3.3	7.4	3.9	23.7	1.1	0.8	7.2	11.3	12.6	22.2	27.5	7.7	4.6	6.4	15.2	8.7	10.2	12.2	14.8	9.9	18.0	6.4	16.8	8.0	10.9	6.5	1.6	18.1	31.5	7.3	7.1	3.4	1.5	13.4	8.2	4.8	2.3	11.5	3.9	21.4	10.1	5.2	11.2	4.8	32.0	4.1	13.9	5.4	0.1	2.4	6.7	7.9	11.2	11.4	1.5	4.9	24.9	10.2	0.0	1.7	0.2	0.1	0.1	4.8	0.0	4.9	0.1	2.1	3.2	0.0	0.1	0.7	2.3	0.2	5.6	0.0	0.0	0.2	0.8	7.7	9.4	10.9	12.3	6.6	5.9	7.5	9.4	15.7	7.3	0.0	5.6	0.0	2.3	1.5	22.3	2.4	7.6	1.4	6.8	10.4	35.3	1.2	5.0	6.1	3.7	1.1	16.0	0.0	7.3	21.6	3.9	2.4	5.8	43.3	1.6	25.4	2.9	4.3	2.7	2.7	1.1	0.7	0.0	0.0	12.4	4.4	12.1	24.6	1.1	5.6	15.9	6.5	3.8	0.2	1.2	6.0	1.7	12.8	12.4	4.4
ELOVL7	FLJ23563	ENSG00000164181	"ELOVL fatty acid elongase 7"	A1L3X0	5	60751791-60844389	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 27.6;Suprabasal keratinocytes: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.8;neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 24.0;HEL: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036337	Approved					NA	NA					"HPA036337: AB_10670797"	"unprognostic (6.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.54e-9)"	"unprognostic (6.95e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.30e-3)"	9.9	5.3	11.4	2.1	15.2	1.1	21.4	7.5	12.4	4.0	7.9	15.0	1.4	10.5	2.8	2.1	5.0	2.4	17.5	1.1	13.8	10.9	15.0	1.2	3.7	2.3	19.0	7.7	0.8	7.6	17.2	3.3	3.1	16.7	20.4	10.8	4.2	3.9	1.5	0.9	23.0	18.9	3.6	26.2	0.9	2.9	1.0	11.7	0.0	15.4	5.0	3.7	5.7	5.0	0.1	0.1	3.8	0.2	0.1	0.1	5.8	11.0	4.1	0.0	0.3	0.0	0.0	10.4	0.0	2.3	1.4	4.9	5.3	11.8	0.0	5.0	0.0	24.0	0.6	7.0	4.5	2.1	15.2	3.7	20.0	0.4	1.7	0.1	1.6	8.5	0.1	8.2	0.1	7.2	0.5	0.0	3.5	3.1	4.0	0.0	9.6	0.0	0.1	1.3	1.0	0.0	0.8	1.2	0.6	10.9	10.6	4.4	0.7	6.1	4.9	2.7	1.2	8.1	0.3	0.1	0.9	5.1	0.1	3.8	10.5	10.4	0.1	7.5	0.4	0.2	3.8	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	2.9	0.1	0.1	0.1	0.0	5.8	11.4	15.2	7.5	12.4	13.8	10.9	19.0	7.7	16.7	11.7	11.9	1.9	0.0	8.3	27.6	3.0	0.7	20.4	2.7	7.9	12.2	0.0	0.1	5.0	6.7	0.0	2.6	11.9	0.0	2.7	0.0	1.5	15.5	12.7	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.9	10.1	2.8	15.9	2.9	5.8	9.9	0.0	7.5	7.3	0.0	1.0	0.1	1.3	33.4	2.4	0.0	11.5	7.8
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 45.4"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		580000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	45.4	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2	0.0	0.0	24.9	0.0	0.1	1.0	1.0	68.8	0.0	0.0	8.7	0.0	0.0	39.7	0.0	75.4	0.6	0.0	0.0	0.0	0.0	0.8	0.5	0.0	338.0	0.1	3.2	0.0	22.7	22.3	92.6	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	322.0	0.4	0.0	0.1	10.7	12.2	0.4	0.0	6.9	0.0	0.0
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 46.7;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;NB-4: 4.0;THP-1: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		67000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.6	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.7	0.0	0.9	0.4	0.4	0.1	0.3	0.4	0.0	0.2	0.1	0.0	0.2	4.0	1.3	0.1	0.7	0.3	0.1	0.1	0.1	0.8	0.2	0.4	0.5	0.1	0.0	0.1	0.0	15.5	0.2	0.1	0.2	0.2	0.2	0.7	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2	0.0	1.4	0.0	0.1	0.1	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	46.7	0.2	0.2	0.0	0.1	0.0	134.4	0.3	0.0	0.0	1.8	6.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.1
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Cell type enriched"	"Detected in some"	7	"granulocytes: 556.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Group enriched"	"Detected in some"	4	"HEL: 61.2;HMC-1: 147.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	61.2	0.0	0.0	0.0	0.1	147.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2	11.9	81.4	0.0	0.0	0.7	0.5	0.3	0.0	8.1	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	556.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 259.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.5	18.8	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.8	4.5	0.3	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.0	60.9	7.9	0.0	0.2	24.9	0.0	6.2	0.0	1.4	4.4	0.1	0.2	0.3	13.1	0.9	0.0	0.2	7.8	10.4	1.6	0.1	0.5	0.0	18.8	31.6	0.1	0.4	5.9	7.7	0.0	31.3	0.2	14.3	1.2	1.3	3.4	1.8	4.4	0.1	0.0	0.2	5.9	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6	26.8	39.0	13.7	77.1	31.6	0.5	1.6	140.1	52.2	86.4	57.6	0.0	45.4	104.5	84.7	1.2	4.9	45.2	0.0	42.0	69.7	45.8	47.7	0.0	146.0	259.0	0.0	15.7	23.4	235.2	1.6	121.7	155.2	54.0	68.5	65.8	22.3	57.9	100.1	99.0	189.5	0.5	77.6	52.5	0.5	0.6	22.6	31.5	5.0	76.2	102.7
MACROD1	LRP16	ENSG00000133315	"MACRO domain containing 1"	Q9BQ69	11	63998558-64166106	"Disease related genes, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 142.5"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 116.0;Proximal tubular cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 27.0;RPMI-8226: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	4.9	3.0	2.9	2.8	3.3	2.5	3.9	6.2	4.6	3.6	6.9	2.8	7.0	4.3	3.4	6.5	7.8	3.2	3.9	29.0	2.2	3.4	10.6	10.4	3.0	1.8	3.0	3.1	5.2	16.6	2.5	2.7	2.1	3.1	6.1	1.9	4.6	16.4	8.1	142.5	5.5	3.9	6.2	2.4	2.7	5.6	1.9	2.7	0.8	12.7	25.0	3.3	4.6	4.5	0.6	0.7	0.0	1.2	0.0	2.0	0.4	4.0	2.1	0.6	3.8	0.6	0.4	3.7	2.3	1.1	1.9	1.8	2.0	11.0	15.4	8.5	0.2	0.6	10.4	0.5	0.0	0.1	1.1	7.2	5.5	8.8	10.9	2.3	4.6	0.6	0.9	1.2	0.2	0.5	1.3	0.7	4.8	5.0	3.1	0.3	27.0	6.4	15.9	1.8	1.4	8.2	5.7	4.3	51.0	0.6	0.2	5.3	11.0	2.1	15.9	14.5	0.0	11.4	0.1	1.0	1.7	2.6	2.6	0.2	6.2	0.9	2.5	1.2	4.7	1.6	0.0	0.2	0.0	2.0	1.2	1.9	0.6	1.8	1.1	0.4	0.4	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.4	2.9	3.3	6.2	4.6	2.2	3.4	3.0	3.1	3.1	2.7	0.0	5.8	10.9	30.6	24.8	13.1	30.8	30.6	0.0	4.5	40.1	0.0	25.1	116.0	16.5	5.8	9.0	17.2	0.0	34.7	10.9	13.7	23.2	0.0	42.3	9.7	11.1	22.0	7.4	2.5	15.9	23.0	1.8	37.1	2.8	52.9	14.3	17.6	28.8	13.4	164.4	15.8	19.4	18.4	2.9	28.5	32.4	20.0	6.1	65.5	30.1
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"MACRO domain containing 2"	A1Z1Q3	20	13995369-16053197	"Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 151.9;Bipolar cells: 89.0;Club cells: 67.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 14.1;granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 14.7;Karpas-707: 18.2;RT4: 8.0;SCLC-21H: 10.0"	"Low region specificity"	"Detected in all"							HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	2.8	5.1	15.2	3.0	47.5	2.0	4.2	20.8	13.6	6.4	2.7	3.7	2.0	1.4	12.1	3.9	2.3	10.3	4.1	1.9	10.5	8.2	5.6	2.7	15.7	5.5	7.6	8.9	4.5	4.2	5.4	12.0	1.8	10.5	7.1	2.1	4.0	2.4	14.9	3.1	3.9	1.8	5.8	6.9	6.9	3.4	7.9	9.9	0.0	4.1	0.1	7.2	10.6	3.1	14.1	0.5	3.8	1.8	0.3	0.6	0.5	1.0	0.6	2.8	0.9	0.9	0.8	0.5	0.5	2.0	1.1	0.6	1.0	0.7	1.9	14.7	1.4	2.6	1.4	0.4	0.7	1.9	1.0	0.9	1.1	1.1	1.9	3.6	0.3	0.3	1.6	1.1	0.0	0.8	1.0	1.1	0.3	1.3	18.2	3.1	0.4	0.5	0.7	1.0	6.3	0.4	1.1	0.5	3.5	2.1	8.0	10.0	4.3	1.5	0.1	0.7	1.3	1.0	1.6	0.8	1.5	3.1	0.2	0.1	1.5	0.5	1.8	0.9	1.0	1.8	0.3	0.6	0.6	0.4	1.3	0.4	7.4	0.3	0.4	0.5	14.1	0.4	0.6	3.8	0.3	1.8	0.2	0.2	0.5	15.2	47.5	20.8	12.8	10.5	8.2	7.6	8.9	10.5	9.9	47.6	151.9	14.5	37.6	3.9	89.0	4.0	12.7	12.0	67.1	12.2	37.3	4.4	8.3	9.1	28.4	2.1	1.1	0.0	1.4	0.2	2.6	4.4	1.1	3.9	0.8	7.9	1.2	2.5	0.3	46.6	3.1	1.0	3.3	0.0	3.7	9.3	4.6	1.1	16.6	5.1	18.6	6.5	4.1	17.9	16.4	5.8	1.7	0.0	2.4	3.8
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 358.2;Proximal tubular cells: 497.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.4	40.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	4.1	1.5	5.4	0.0	0.0	0.6	1.6	0.1	4.3	75.9	0.0	4.1	19.1	21.4	0.0	11.2	0.0	4.8	0.0	0.0	0.1	1.4	0.6	0.0	0.1	0.4	4.9	1.2	0.0	0.0	0.1	5.5	31.3	0.7	1.9	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7	65.5	115.2	10.9	141.7	9.7	4.4	90.1	91.7	34.8	50.0	57.6	21.6	9.7	102.8	29.5	19.6	35.3	358.2	0.0	12.0	17.7	14.2	55.4	5.7	169.3	6.2	3.2	36.6	36.8	14.9	22.5	5.2	4.0	10.1	29.7	119.4	23.2	31.4	140.8	0.0	497.3	21.7	6.5	15.1	1.1	0.4	12.5	173.1	3.1	215.1	89.9
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766611-43882447	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 104.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 111.3;granulocytes: 138.1;Hepatocytes: 197.3;Peritubular cells: 89.5;Proximal tubular cells: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.6;SiHa: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced					NA	NA		3600000			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	25.0	18.2	24.8	3.9	34.8	0.5	16.5	5.5	24.5	12.0	18.9	20.3	15.6	24.9	38.0	20.0	11.4	34.9	15.4	32.4	21.2	46.9	41.8	104.9	10.9	2.3	24.4	19.9	56.0	4.1	15.6	8.9	9.4	26.8	30.1	6.3	3.0	38.0	55.9	34.8	3.0	30.5	35.9	39.1	1.3	8.4	5.2	21.3	0.2	1.8	8.2	2.8	12.1	8.5	0.0	0.0	0.0	0.1	0.0	1.0	1.2	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	20.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.6	39.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	24.8	34.8	5.5	24.5	21.2	46.9	24.4	19.9	26.8	21.3	0.0	5.5	0.0	0.4	4.8	1.0	111.3	38.2	21.4	3.4	5.2	3.9	0.3	53.0	15.6	0.1	11.3	8.0	0.0	2.5	0.7	11.2	0.6	138.1	197.3	1.4	14.3	0.0	4.9	4.7	0.4	42.6	1.3	6.8	0.0	2.9	25.5	4.7	8.0	89.5	130.3	0.7	12.9	15.6	0.0	0.1	3.4	0.3	4.3	3.9	0.3
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	32.1	33.9	6.4	20.8	9.1	9.6	18.1	11.3	6.6	15.5	13.6	22.0	10.2	24.5	37.7	9.3	20.1	15.4	13.4	13.6	6.0	10.2	62.5	8.8	23.7	22.1	12.5	17.1	19.5	7.3	15.3	14.4	15.0	7.8	17.5	9.6	17.6	10.4	10.2	42.2	27.3	25.5	10.7	30.4	47.1	21.7	16.5	26.8	11.3	14.8	13.7	16.5	4.4	17.9	26.7	6.3	9.6	14.2	10.1	6.5	22.3	22.5	34.3	22.0	24.5	46.0	8.8	22.1	18.9	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8	8.9	27.5	83.3	53.7	62.3	28.9	38.0	53.5	29.4	26.1	36.6	11.8	113.1	81.2	114.3	2.1	90.5	71.7	46.7	129.7	161.7	59.9	66.0	66.9	63.8	109.5	35.0	55.8	64.4	62.9	8.3	43.1	71.4	113.1	75.7	61.8	26.2	121.2	58.3	43.9	155.0	22.4	64.7	78.5	5.8	39.4	79.2	91.0	68.3	80.9	64.7
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	25.1	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	21.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	14.4	15.0	0.0	11.1	0.0	0.0	0.0
NAA15	"FLJ13340, NARG1, NATH, TBDN100"	ENSG00000164134	"N(alpha)-acetyltransferase 15, NatA auxiliary subunit"	Q9BXJ9	4	139301455-139420033	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023589, HPA050661"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA023589: AB_1854311, HPA050661: AB_2681208"	"unprognostic (6.25e-3)"	"unprognostic (5.95e-2)"	"unprognostic (7.80e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.16e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.65e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.58e-1)"	13.7	12.9	13.7	17.8	14.2	18.6	15.2	21.0	18.9	10.8	12.3	7.8	9.0	10.1	13.4	9.8	20.5	11.4	9.7	14.8	16.6	10.1	10.3	14.5	13.3	17.7	15.6	10.7	13.1	11.4	16.8	20.3	14.0	13.8	11.6	12.6	6.7	13.8	10.4	54.4	13.8	10.3	19.3	22.2	12.2	11.4	17.6	15.9	18.0	12.2	22.3	19.9	15.3	15.1	8.7	7.1	4.1	5.6	6.8	9.4	3.1	16.8	12.4	12.0	19.3	8.8	10.8	14.8	16.4	10.8	15.9	12.3	17.4	14.9	34.8	10.1	13.5	13.8	11.0	31.4	20.1	22.9	16.2	11.6	18.7	12.0	11.3	9.3	34.0	12.1	7.6	12.3	20.0	15.7	8.4	15.8	13.7	34.5	15.2	16.8	13.5	32.4	10.1	20.0	31.9	9.8	20.2	16.2	17.9	12.6	14.3	15.7	12.3	10.9	18.0	10.9	12.7	10.9	13.4	13.5	15.4	10.8	14.5	18.6	18.5	33.0	34.6	13.2	24.9	14.6	4.1	5.4	1.7	8.0	5.6	9.3	7.4	8.4	9.4	7.1	8.7	8.3	9.3	4.1	6.8	5.3	6.0	8.0	3.1	13.7	14.2	21.0	18.9	16.6	10.1	15.6	10.7	13.8	15.9	44.7	29.8	38.0	57.7	83.0	32.8	40.0	33.1	40.2	39.8	19.2	19.6	34.9	13.3	24.8	5.1	26.3	10.0	23.3	16.8	38.0	39.1	29.9	33.5	22.9	28.5	38.1	15.0	11.1	25.3	8.2	23.6	28.7	27.0	26.2	18.1	25.1	20.6	17.5	27.3	13.6	35.4	32.3	30.9	81.6	51.1	86.8	34.9	28.8	24.7	61.8
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N(alpha)-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017116-20033655	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol		NA	NA			Cytosol		"HPA063344: AB_2684991"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	15.9	20.0	14.2	10.0	21.4	17.4	23.2	15.5	34.1	17.3	12.7	12.0	22.7	9.7	20.5	17.7	58.4	15.8	12.3	24.1	14.7	14.1	24.6	25.0	15.7	19.0	13.1	18.3	12.9	43.2	24.8	20.0	18.5	19.4	14.4	12.2	11.2	22.0	20.6	35.2	15.6	11.0	17.3	13.1	11.0	14.5	43.7	10.2	9.5	23.6	37.5	22.1	14.0	23.7	18.6	28.3	20.4	27.5	17.7	25.8	26.4	40.5	24.6	8.9	13.9	18.8	19.8	13.4	30.0	20.5	27.0	25.3	12.6	29.4	22.0	16.3	20.2	21.8	32.2	15.2	48.1	22.0	9.9	16.5	16.5	6.5	18.8	27.0	17.4	12.2	22.5	31.7	27.4	27.7	15.6	23.2	15.8	26.7	22.8	23.5	31.7	24.5	18.2	6.9	28.1	40.3	13.5	35.1	29.2	26.6	9.4	16.9	11.5	18.1	51.2	25.0	6.1	31.6	28.1	25.2	22.5	13.2	27.0	27.5	24.8	30.9	23.8	13.6	15.3	16.0	8.0	27.5	20.4	17.6	27.5	25.8	18.6	20.5	20.2	28.3	16.5	19.9	22.0	3.6	17.7	23.2	22.9	20.8	26.4	14.2	21.4	15.5	34.1	14.7	14.1	13.1	18.3	19.4	10.2	62.5	35.6	41.7	83.1	96.6	54.1	70.6	71.4	99.0	55.7	99.5	23.6	98.0	195.6	180.5	209.7	76.7	31.4	0.0	145.5	94.1	66.4	74.5	49.7	69.9	213.0	65.2	39.6	52.2	51.1	27.3	64.7	64.9	67.4	121.8	44.4	78.6	191.0	35.1	70.4	177.4	48.7	38.8	66.9	234.3	53.9	103.8	71.5	45.7	56.2	118.5
NAA30	"C14orf35, FLJ35355, MAK3, Mak3p, NAT12"	ENSG00000139977	"N(alpha)-acetyltransferase 30, NatC catalytic subunit"	Q147X3	14	57390544-57415917	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057824	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA057824: AB_2683539"	"unprognostic (5.13e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.25e-8)"	"unprognostic (1.77e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.63e-1)"	10.7	10.3	15.8	10.7	18.3	15.0	16.4	18.1	18.9	9.9	15.0	9.2	8.6	11.4	12.1	8.8	13.5	9.1	12.5	18.8	13.9	15.6	14.7	19.1	8.2	9.6	12.9	16.4	18.1	10.5	16.2	13.4	15.4	12.0	12.3	9.6	9.6	10.8	12.8	34.9	10.5	13.5	13.0	9.9	9.8	8.6	21.4	10.1	15.0	12.6	13.6	10.3	12.8	13.7	2.6	1.5	1.7	5.3	5.5	4.2	0.8	14.1	13.6	7.8	12.7	13.2	17.3	13.2	16.6	16.1	12.7	11.6	12.2	10.5	10.4	14.7	13.7	9.7	15.0	14.0	10.7	21.3	18.0	7.2	8.4	7.8	10.6	13.8	16.8	9.8	11.7	16.0	11.5	19.3	14.2	19.5	13.0	8.2	10.4	16.8	16.3	14.0	9.8	8.3	13.1	15.2	11.2	22.5	8.1	13.1	12.9	16.8	8.8	14.0	13.9	16.8	14.6	17.8	8.8	17.0	20.0	21.0	10.9	10.5	7.7	9.3	12.7	13.2	8.5	14.1	1.7	0.9	0.5	2.9	2.1	3.0	2.3	2.8	4.2	0.8	2.6	3.0	2.8	0.4	5.5	5.3	1.5	3.7	0.8	15.8	18.3	18.1	18.9	13.9	15.6	12.9	16.4	12.0	10.1	8.9	7.5	12.0	10.0	36.5	12.8	36.4	15.3	6.7	5.7	3.5	17.7	14.5	8.3	11.2	72.4	16.1	8.5	0.0	10.2	13.2	13.2	14.3	6.9	21.2	8.7	9.5	20.2	11.6	10.7	23.6	12.7	6.9	21.9	8.2	14.6	12.3	11.8	11.9	12.7	13.7	13.4	19.4	12.3	44.7	16.9	36.0	18.5	14.6	10.9	12.4
NAA60	"FLJ14154, NAT15"	ENSG00000122390	"N(alpha)-acetyltransferase 60, NatF catalytic subunit"	Q9H7X0	16	3443611-3486963	"Enzymes, Predicted intracellular proteins"	"Chromosome partition"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040916	Approved		Uncertain	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA040916: AB_10794428"	"unprognostic (8.59e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.39e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.81e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.74e-3)"	18.5	28.7	24.2	17.9	30.8	26.6	16.2	38.1	40.2	17.1	29.4	29.1	34.0	36.8	24.3	18.6	21.3	21.7	23.7	26.2	25.6	21.3	35.8	40.3	23.6	19.4	21.6	17.7	21.2	41.8	46.4	29.0	27.0	24.4	23.7	21.4	29.1	20.7	31.6	38.9	16.9	42.2	19.9	25.7	28.1	34.8	25.3	19.0	22.8	21.8	21.8	24.1	21.7	22.1	8.5	11.2	34.8	13.2	11.6	13.4	10.0	8.2	32.5	23.0	24.2	18.4	12.6	20.6	15.8	16.9	16.4	14.8	22.2	17.8	17.2	16.1	18.0	11.7	19.3	22.7	18.4	16.0	25.8	15.3	20.9	20.5	26.0	19.9	26.7	27.7	15.4	14.3	11.2	21.7	20.2	26.2	15.4	22.0	24.5	11.5	37.8	16.8	19.7	28.0	21.9	9.5	21.1	17.4	26.0	16.9	17.4	12.2	26.4	23.5	26.2	12.5	23.0	23.4	18.9	19.3	21.1	18.1	6.8	14.6	20.5	19.0	16.7	6.7	16.6	16.1	19.8	10.5	34.8	11.8	12.3	12.5	8.0	10.8	11.5	11.2	8.5	9.3	10.8	13.2	11.6	13.2	7.8	13.4	10.0	24.2	30.8	38.1	40.2	25.6	21.3	21.6	17.7	24.4	19.0	8.9	16.5	13.7	11.2	0.1	21.2	12.6	35.7	6.7	10.3	12.2	5.9	22.8	36.5	27.5	41.1	18.6	61.4	0.0	36.4	33.1	15.4	16.7	30.0	42.3	27.8	11.1	25.9	27.6	28.5	44.0	10.6	14.5	0.0	26.2	34.4	20.8	29.9	45.6	14.9	32.7	14.2	25.8	11.2	14.9	20.2	0.3	27.6	21.0	31.9	22.0
NAAA	ASAHL	ENSG00000138744	"N-acylethanolamine acid amidase"	Q02083	4	75913657-75941051	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 89.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 97.1;Kupffer cells: 106.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 31.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 89.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 89.9"	"Cell line enhanced"	"Detected in many"		"U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026135	Approved				"Intracellular and membrane"	NA	NA					"CAB026135: "	"unprognostic (5.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.21e-2)"	11.2	6.7	5.8	12.3	10.3	6.5	16.9	10.2	10.5	10.8	26.4	6.0	6.0	13.1	9.8	7.1	12.5	8.4	6.8	9.5	7.0	8.2	18.2	29.6	10.0	52.2	11.8	5.3	6.1	6.9	5.5	9.0	8.2	9.1	32.4	31.2	16.6	19.8	5.1	6.2	11.2	34.0	10.2	11.2	44.9	9.8	3.4	6.9	10.2	11.2	8.0	19.5	10.3	12.6	8.1	19.7	14.3	89.9	4.5	15.1	25.9	4.4	10.1	0.4	0.3	24.6	25.0	0.4	6.6	4.4	4.6	1.5	3.4	15.7	0.4	3.5	16.3	0.1	8.8	13.2	5.1	2.8	6.3	0.5	3.1	7.5	8.3	5.7	11.5	11.5	6.3	3.9	4.0	1.4	7.1	7.3	7.1	3.4	13.8	4.0	16.2	7.3	7.5	5.1	19.8	4.0	5.0	0.1	20.5	4.8	2.5	6.1	0.9	6.8	21.6	1.9	0.7	24.3	20.1	10.8	0.2	0.6	30.4	0.3	3.4	1.3	2.2	5.8	16.6	2.8	5.5	37.2	14.3	9.0	89.9	9.7	8.1	11.5	8.9	19.7	5.3	9.7	8.1	12.5	4.5	74.4	7.3	15.1	25.9	5.8	10.3	10.2	10.5	7.0	8.2	11.8	5.3	9.1	6.9	0.0	8.2	28.2	16.1	10.1	9.6	3.9	28.1	24.1	6.8	5.2	17.7	21.0	11.6	4.6	0.4	11.7	97.1	0.0	7.4	16.3	27.2	69.0	14.0	30.2	35.4	11.1	46.1	17.8	106.0	0.0	9.8	77.1	16.9	16.2	28.2	6.5	3.9	28.5	7.1	9.2	78.9	0.0	18.4	0.7	0.9	16.6	11.1	36.2	21.4	12.1
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037853-15056079	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	24.2	8.3	11.7	8.1	11.7	11.9	48.2	5.2	12.1	16.1	18.0	5.4	8.6	6.8	14.4	24.5	14.6	10.2	12.2	23.2	8.0	6.0	10.6	16.9	13.5	12.4	7.4	8.0	13.0	13.3	7.6	5.0	7.8	9.8	15.9	15.7	17.9	11.1	7.7	14.4	13.6	9.7	19.8	7.4	13.7	12.9	14.0	6.4	8.1	10.5	12.7	11.7	18.8	19.9	9.4	12.0	31.2	5.7	5.3	12.3	5.2	10.0	7.3	8.8	7.6	11.3	21.8	3.3	12.2	16.6	12.5	21.6	3.4	7.5	6.9	9.7	23.2	9.8	4.2	7.0	14.3	17.5	6.6	9.7	4.0	6.6	18.8	11.6	2.9	2.2	11.3	8.5	12.0	4.6	7.9	28.3	10.3	4.7	7.9	23.2	8.4	5.9	12.3	6.4	11.7	8.2	11.8	12.0	9.3	9.0	13.9	2.7	10.0	5.0	1.8	8.6	17.9	3.3	4.5	15.9	18.1	7.2	7.6	10.7	7.7	15.3	9.1	10.9	6.5	8.2	2.5	4.1	31.2	5.5	5.7	6.5	9.4	7.2	7.3	3.8	6.1	5.9	3.7	1.9	5.3	5.5	12.0	12.3	5.2	11.7	11.7	5.2	12.1	8.0	6.0	7.4	8.0	9.8	6.4	3.0	4.6	27.4	13.7	29.9	5.6	2.5	10.2	4.0	13.6	17.4	9.8	62.9	38.1	42.6	39.3	51.7	10.5	0.0	20.6	15.7	22.3	22.4	8.1	16.4	96.7	23.8	6.4	46.1	47.3	19.7	76.8	45.7	55.6	55.9	8.1	7.8	42.1	11.8	70.7	27.1	7.4	38.8	29.7	26.5	27.7	19.1	47.6	28.4	14.2	19.2
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 72.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	14.6	19.1	19.1	15.8	19.3	15.3	19.3	13.2	20.2	13.6	17.4	18.8	30.3	19.1	12.6	26.6	15.8	20.1	15.9	13.5	19.1	18.6	27.8	35.4	16.2	24.8	21.4	19.6	22.5	25.3	21.6	22.4	13.8	20.9	16.8	20.4	17.6	15.9	24.2	16.7	14.9	17.9	15.8	21.4	16.2	22.7	44.7	20.9	21.4	24.6	14.2	20.7	16.0	14.1	27.6	16.5	23.4	16.2	27.4	24.4	13.2	11.4	7.4	16.0	10.8	9.2	10.6	9.5	7.0	10.1	8.4	9.4	11.1	8.4	15.8	7.8	4.3	9.2	8.5	9.9	9.5	12.5	13.9	5.4	19.2	7.8	20.8	8.7	13.2	12.6	8.3	14.0	8.1	27.9	7.6	5.8	20.5	24.4	13.6	9.0	17.1	21.4	15.5	15.1	72.4	4.9	10.0	14.0	15.4	16.6	6.3	16.8	11.3	6.6	6.7	23.0	12.8	11.8	12.2	6.0	8.7	10.3	5.6	12.1	18.0	17.9	35.3	7.2	13.4	7.4	20.4	13.8	23.4	17.2	14.2	21.6	27.6	19.7	17.0	16.5	25.8	24.4	23.2	13.4	27.4	16.2	16.0	21.8	13.2	19.1	19.3	13.2	20.2	19.1	18.6	21.4	19.6	20.9	20.9	14.9	40.0	42.2	37.8	25.3	59.8	37.9	43.3	57.6	34.2	57.6	43.2	77.5	72.9	37.0	142.4	30.6	31.5	0.0	42.0	52.6	25.1	27.9	47.3	57.2	39.6	39.7	21.2	19.6	46.1	120.0	26.2	34.7	33.7	36.9	47.2	59.6	29.7	43.8	24.4	76.7	60.3	25.8	35.0	186.5	159.6	25.6	38.1	48.9	57.7	23.1
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884669-67918390	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	17.2	32.3	12.6	21.1	17.8	17.0	18.1	22.6	14.5	24.2	20.5	15.7	14.0	9.2	19.0	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17.0	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15.0	21.0	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.3	9.6	15.2	16.9	14.5	11.2	9.5	11.6	12.0	16.0	14.3	10.5	7.2	17.6	6.3	7.7	10.0	6.7	18.8	3.9	17.2	9.4	10.9	9.3	7.2	8.2	13.3	10.0	7.2	10.3	9.4	9.6	16.6	17.2	6.4	10.1	11.8	9.6	11.6	6.7	9.3	13.9	18.8	5.4	15.3	16.9	12.0	6.9	7.5	5.2	9.8	13.5	21.3	14.1	14.7	13.7	10.2	9.3	5.3	12.5	11.6	11.0	11.2	8.1	9.6	34.9	6.4	15.2	5.1	3.8	2.4	3.2	3.4	3.0	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17.0	10.1	12.1	16.3	17.9	6.1	10.4	16.4	34.8	11.7	27.0	15.3	1.4	9.1	5.2	25.5	5.7	5.0	3.9	171.4	12.8	17.4	23.3	4.7	4.3	17.6	23.9	11.5	14.8	7.8	11.1	41.1	14.1	20.9	29.0	16.4	13.5	15.1	1.8	16.9	7.0	6.4	10.5	18.4	6.3	13.4	0.0	38.2	20.6	15.4	41.5	10.4	13.8	12.4	14.9
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.6;skeletal muscle: 108.7"	"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 174.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"	Nucleoplasm	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	14.1	11.0	30.2	8.1	36.0	10.7	9.1	14.3	38.8	11.0	8.4	78.1	4.0	9.3	9.7	7.8	17.1	12.9	10.7	20.3	36.9	23.5	9.0	12.0	10.8	8.8	52.3	20.5	17.3	9.5	10.1	6.2	7.7	40.8	9.8	7.6	5.8	14.9	11.2	108.7	13.7	9.3	12.8	86.6	9.9	9.0	7.9	46.3	3.2	10.1	23.4	8.9	10.6	7.1	13.2	21.5	28.0	33.0	16.6	23.5	22.1	8.2	5.2	4.4	11.1	25.6	17.6	3.0	6.1	10.9	9.5	12.3	9.3	5.3	2.9	13.3	11.3	7.3	4.5	8.1	13.1	5.8	13.2	8.4	5.6	5.9	5.6	18.1	3.9	12.4	18.4	15.8	7.8	9.4	11.8	16.7	9.4	5.2	22.9	14.5	4.7	7.8	3.0	0.7	14.1	7.3	10.4	12.6	8.0	7.7	7.4	11.3	5.1	7.1	9.5	6.7	3.9	4.3	10.1	15.8	12.9	2.8	19.9	9.0	9.4	4.5	6.6	10.3	9.8	11.9	19.5	27.3	28.0	23.5	33.0	14.6	12.2	11.4	16.1	21.1	13.2	7.5	12.5	20.7	16.6	25.8	21.5	15.5	22.1	30.2	36.0	14.3	38.8	36.9	23.5	52.3	20.5	40.8	46.3	14.9	20.8	11.4	27.5	45.8	26.8	30.8	7.6	29.4	20.5	12.2	33.4	28.9	31.5	27.0	174.5	26.3	34.2	23.3	15.3	12.8	23.1	19.4	25.3	16.2	56.7	28.6	16.8	23.9	33.7	57.6	28.7	34.2	43.9	14.4	20.4	20.6	21.1	18.6	38.5	23.3	27.0	19.4	35.0	12.7	5.9	52.6	35.4	43.6	15.8	22.6
SIRT3	SIR2L3	ENSG00000142082	"Sirtuin 3"	Q9NTG7	11	215458-236931	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026809, CAB037142"	Approved					NA	NA					"CAB037142: AB_1079982, HPA026809: AB_10601160"	"unprognostic (1.76e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.85e-9)"	"unprognostic (1.04e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.75e-2)"	8.2	9.3	15.1	8.2	26.3	8.6	17.4	16.7	24.5	8.4	9.9	16.2	8.2	11.2	11.2	36.8	8.4	13.2	6.9	19.8	14.7	14.8	10.4	15.2	8.6	10.7	11.9	16.2	17.4	12.8	15.0	18.7	6.1	17.1	12.6	12.9	15.4	12.0	11.9	21.2	17.3	11.3	9.2	8.8	11.1	9.0	16.5	11.9	4.4	13.4	9.3	12.6	7.9	7.1	7.2	6.3	3.7	8.0	10.5	9.3	4.0	7.1	9.7	13.2	14.0	16.6	19.6	6.5	10.2	9.4	8.8	7.1	8.1	17.1	4.5	4.8	7.0	7.8	13.2	6.6	6.1	8.2	8.5	9.5	5.5	9.9	10.0	7.0	7.2	13.8	15.3	12.1	8.1	9.0	14.2	5.5	8.8	11.3	8.9	4.0	8.8	3.0	11.2	6.0	7.3	10.8	8.0	10.9	7.4	8.8	4.9	7.7	6.1	8.6	13.4	4.5	8.9	9.7	1.8	7.4	9.0	4.3	2.5	3.0	15.6	12.4	6.0	9.5	6.0	4.8	0.0	4.2	3.7	5.6	3.6	6.2	7.2	5.2	6.4	4.0	6.8	9.3	7.6	2.4	10.5	8.0	6.3	5.5	4.0	15.1	26.3	16.7	24.5	14.7	14.8	11.9	16.2	17.1	11.9	3.0	6.2	7.6	6.9	4.4	6.6	20.2	10.2	6.7	4.5	5.2	7.9	10.1	28.2	6.4	17.0	6.0	8.0	0.0	5.1	9.1	7.5	4.8	10.3	16.3	7.6	9.5	5.8	8.0	2.7	17.6	8.3	3.8	10.1	3.6	8.4	11.5	4.4	8.7	8.5	15.7	8.4	0.0	5.2	17.0	11.4	3.6	5.7	6.1	9.8	3.9
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574529-13615158	"FDA approved drug targets, Predicted intracellular proteins"		Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 47.2;Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	5.9	6.2	8.8	6.8	10.4	5.9	9.2	11.1	13.5	4.9	7.2	6.4	12.5	8.1	6.8	6.7	5.7	8.0	6.6	22.9	8.5	8.3	9.9	29.9	9.8	6.9	9.5	6.9	8.8	10.5	12.9	7.6	5.3	8.3	6.5	8.3	6.2	8.6	8.7	25.8	8.8	8.5	6.2	6.9	9.5	7.6	6.6	6.1	7.5	8.5	7.0	6.5	6.8	6.0	9.2	4.6	10.9	9.3	7.3	10.0	5.6	5.8	4.6	5.9	7.6	3.7	4.8	4.4	3.0	3.2	3.3	5.0	7.3	7.0	8.4	18.3	2.4	7.3	9.5	4.1	5.9	5.0	3.8	6.8	5.3	4.2	11.8	6.1	4.3	4.6	5.2	12.1	2.9	10.4	7.2	6.0	11.9	7.5	3.2	3.9	7.1	4.7	8.5	4.9	9.1	7.3	8.4	3.8	15.3	6.8	6.4	9.7	3.5	3.4	5.9	13.4	16.7	6.8	2.8	5.3	5.1	2.9	3.1	3.3	7.8	8.8	5.7	2.9	4.3	4.8	0.5	4.5	10.9	8.1	6.1	8.2	9.2	10.0	7.9	4.6	9.1	9.5	8.5	1.5	7.3	9.3	4.6	7.2	5.6	8.8	10.4	11.1	13.5	8.5	8.3	9.5	6.9	8.3	6.1	26.8	2.7	9.1	9.2	3.7	6.4	47.2	10.2	21.4	17.0	10.4	0.0	17.1	44.7	10.5	2.2	8.7	9.6	23.3	6.0	9.0	4.9	5.7	0.0	22.2	8.5	1.6	5.8	10.4	10.4	0.5	7.5	6.1	5.0	5.4	12.6	8.4	6.7	13.9	5.3	24.0	6.2	0.0	5.0	6.5	7.8	4.0	8.9	6.9	16.5	7.3
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182604	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA049729: AB_2680865, HPA071776: AB_2686445"	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favorable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.58e-4)"	9.5	11.7	9.4	14.6	11.5	17.8	8.0	15.2	16.3	9.0	26.3	11.0	14.8	19.3	10.6	11.9	11.1	8.9	9.9	11.4	9.5	9.0	12.1	14.2	8.7	12.7	10.8	8.5	8.1	17.3	9.4	13.4	12.1	8.2	12.0	15.3	10.9	12.1	11.9	10.2	13.0	18.4	8.0	7.9	15.1	15.3	6.6	7.0	14.4	10.7	10.0	11.9	8.1	8.9	10.7	14.1	12.4	16.2	5.1	12.0	8.0	14.1	9.6	4.9	6.1	3.8	3.5	7.6	6.9	5.2	5.9	5.2	6.4	5.4	9.2	7.6	4.6	5.4	9.1	2.7	7.6	0.9	17.3	5.4	3.8	5.1	5.8	8.6	9.7	14.9	4.8	6.0	6.1	3.8	4.7	5.2	8.7	8.4	21.1	3.1	10.7	13.4	10.2	8.3	5.3	8.9	10.5	4.5	10.4	5.6	6.4	6.5	10.5	6.2	5.9	13.3	2.0	5.9	12.9	7.9	6.0	6.1	21.0	10.2	26.7	14.0	10.0	12.0	15.6	7.2	5.2	13.4	11.3	11.6	16.2	6.5	10.5	7.8	9.3	14.1	10.7	6.9	6.5	12.4	5.1	12.5	11.9	12.0	8.0	9.4	11.5	15.2	16.3	9.5	9.0	10.8	8.5	8.2	7.0	11.9	8.2	13.7	8.9	9.2	10.5	2.8	10.2	8.1	9.1	5.2	17.7	19.3	11.6	28.5	1.3	6.6	70.3	0.0	23.0	20.0	8.5	7.5	5.7	6.6	21.6	12.7	25.3	14.1	8.7	1.4	10.6	14.0	5.0	34.3	23.1	10.3	25.4	29.8	7.8	11.6	13.0	0.0	8.5	7.0	9.1	11.0	21.4	10.5	24.3	11.1
SIRT7		ENSG00000187531	"Sirtuin 7"	Q9NRC8	17	81911939-81921323	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 17.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027284, HPA028246, CAB037261, HPA053669"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224"	"unprognostic (8.15e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (3.03e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (4.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.16e-2)"	6.2	5.9	6.7	10.1	12.8	22.6	6.4	17.0	11.4	8.2	12.9	7.0	9.0	14.3	5.5	4.6	28.8	7.2	10.6	3.9	6.7	2.6	7.9	9.8	7.9	11.3	11.0	6.6	4.8	18.7	4.9	7.8	8.8	7.6	7.1	6.7	3.7	12.7	7.0	5.3	15.7	15.3	5.1	5.7	14.1	18.4	8.9	8.8	8.3	6.7	7.3	16.4	8.3	12.3	3.9	1.8	17.4	3.4	1.3	2.6	1.2	15.3	12.8	1.6	5.6	4.2	4.0	10.3	7.8	6.6	9.2	8.7	11.0	12.3	6.9	6.1	4.3	5.8	11.1	6.3	4.8	3.0	5.9	13.6	6.0	6.2	17.3	12.8	7.8	12.4	4.0	15.2	8.8	7.3	3.8	6.8	3.8	6.4	3.4	4.3	12.1	8.3	11.1	4.0	23.9	13.3	5.6	3.3	6.4	8.9	10.1	6.7	8.8	9.0	21.7	10.0	3.2	9.0	18.7	5.3	4.1	9.1	7.7	14.1	5.7	1.8	5.0	10.1	10.7	6.7	3.0	2.3	17.4	2.6	3.4	0.9	3.3	2.0	2.1	1.2	3.9	1.8	0.6	3.8	1.3	2.6	1.8	1.0	1.2	6.7	12.8	17.0	11.4	6.7	2.6	11.0	6.6	7.6	8.8	11.9	9.8	27.4	19.4	33.8	22.2	4.0	20.4	16.0	3.4	17.4	53.0	25.1	8.3	18.8	17.0	15.3	59.6	0.0	12.0	29.1	12.9	25.0	11.5	14.7	23.3	28.6	19.5	14.1	19.8	9.1	13.3	24.8	23.6	45.9	28.5	19.3	36.4	49.1	9.6	10.5	35.9	0.0	17.5	37.1	38.4	48.6	41.2	44.8	31.8	44.5
TRMT12	"FLJ20772, Trm12, TYW2"	ENSG00000183665	"TRNA methyltransferase 12 homolog"	Q53H54	8	124450820-124462150	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.2"	"Low region specificity"	"Detected in all"							HPA023939	Approved		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA023939: AB_1848793"	"unprognostic (2.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.99e-5)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.25e-4)"	"unprognostic (1.04e-2)"	10.8	11.6	16.7	8.4	20.9	4.1	15.0	13.8	18.3	11.8	9.5	8.0	6.8	7.5	11.9	10.7	9.6	13.2	8.6	9.9	19.4	9.9	12.9	9.8	9.8	11.8	13.6	14.3	8.8	10.1	14.7	17.7	8.9	14.7	12.0	11.2	7.8	12.0	11.0	18.0	9.9	9.6	14.3	12.9	11.0	10.6	11.7	13.4	9.1	14.9	12.0	10.7	10.2	8.5	5.8	5.0	6.3	6.1	5.1	7.6	4.4	7.4	6.5	5.4	4.2	10.3	5.3	1.3	4.7	5.6	7.0	6.0	4.0	5.2	7.6	6.6	4.8	4.5	5.2	7.7	7.8	8.3	7.5	5.9	7.3	6.2	1.3	8.1	0.0	6.0	6.6	10.4	6.8	8.7	2.0	5.8	8.0	10.2	5.3	4.3	37.2	8.6	3.1	0.0	17.4	6.1	2.7	3.6	5.0	6.4	8.1	9.2	7.4	7.0	26.2	9.8	4.8	7.4	3.1	4.6	4.9	12.8	3.6	5.3	5.5	7.7	2.9	4.4	2.6	3.9	0.5	6.1	6.3	4.5	4.9	5.6	4.0	6.1	4.6	5.0	5.8	7.6	7.4	2.4	5.1	5.5	1.5	3.7	4.4	16.7	20.9	13.8	18.3	19.4	9.9	13.6	14.3	14.7	13.4	8.9	6.9	5.9	5.4	4.6	5.6	2.7	7.6	8.1	1.2	3.5	15.7	5.8	5.0	4.9	11.1	5.2	3.6	0.0	5.4	4.5	3.3	3.4	9.2	5.1	4.5	7.9	2.9	3.7	3.2	14.2	3.7	3.3	5.0	2.8	4.2	3.9	3.6	3.5	5.6	6.6	8.3	0.0	5.5	10.7	3.8	3.8	4.1	4.3	3.7	4.3
UBIAD1	"SCCD, TERE1"	ENSG00000120942	"UbiA prenyltransferase domain containing 1"	Q9Y5Z9	1	11273206-11296049	"Disease related genes, Predicted membrane proteins"	"Menaquinone biosynthesis, Ubiquinone biosynthesis"	"Prenyltransferase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044862			Approved	Vesicles		NA	NA			Vesicles		"HPA044862: AB_2679117"	"unprognostic (1.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-3)"	"unprognostic (7.55e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.80e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.25e-1)"	12.1	11.8	9.2	10.2	11.8	9.2	12.0	10.2	13.1	9.6	9.8	17.6	5.0	7.8	13.0	9.7	8.8	14.4	11.9	11.6	9.0	8.3	9.9	38.1	8.7	18.6	14.1	6.1	17.5	23.4	14.6	10.0	9.1	11.0	10.6	10.0	11.9	11.2	10.2	24.8	11.3	9.5	11.5	15.5	12.9	10.7	17.7	13.6	17.9	12.2	9.6	17.5	11.7	8.7	22.0	10.7	9.5	8.7	9.6	27.0	11.4	8.5	8.5	6.8	13.0	5.0	4.7	9.1	9.4	7.7	10.2	9.3	9.8	7.9	16.9	9.7	6.7	9.6	11.8	17.1	11.3	12.5	11.8	14.7	11.3	9.1	13.0	9.2	17.2	9.9	7.1	15.4	13.7	16.4	5.4	7.4	15.7	13.4	14.1	6.8	8.7	11.1	8.7	8.1	16.1	12.6	10.6	15.1	20.5	7.8	5.7	8.4	9.0	10.0	10.0	12.7	2.9	7.4	9.1	6.1	9.0	9.7	9.3	12.2	11.5	15.9	31.5	5.7	22.9	11.1	4.8	6.5	9.5	13.1	8.7	14.6	22.0	17.8	13.3	8.6	20.7	27.0	18.3	2.0	9.6	7.3	10.7	16.6	11.4	9.2	11.8	10.2	13.1	9.0	8.3	14.1	6.1	11.0	13.6	8.9	13.4	15.8	11.6	13.7	11.1	8.4	7.6	10.7	23.9	5.2	7.9	8.9	10.0	8.9	26.6	8.4	5.1	23.3	11.2	12.1	10.3	9.4	6.9	18.6	7.9	12.7	4.7	4.3	6.9	17.6	11.5	11.3	5.0	5.4	9.7	9.8	9.3	3.5	10.3	7.9	13.9	0.0	10.3	16.1	13.8	11.0	15.8	12.1	13.1	8.9
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481281-126517773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 50.7"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 31.8"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	8	"NB-4: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		510000			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	31.8	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDYHV1	"C8orf32, FLJ10204"	ENSG00000156795	"WDYHV motif containing 1"	Q96HA8	8	123416725-123467230	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.8"	"Low region specificity"	"Detected in all"							"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	10.5	15.5	13.2	7.9	13.6	6.3	17.2	14.3	16.8	14.5	9.9	13.9	10.7	5.8	11.2	12.0	10.2	9.8	8.8	24.8	12.8	19.8	13.6	9.1	8.6	11.4	17.0	10.8	20.4	21.3	9.0	12.8	8.2	16.2	13.5	9.5	9.7	8.3	12.5	19.2	9.8	5.4	13.0	17.0	7.9	10.0	17.5	15.6	5.3	14.4	9.1	11.3	10.1	9.1	5.9	7.2	8.7	7.5	13.1	9.2	5.5	9.1	10.8	12.7	6.7	5.5	12.6	5.7	7.6	6.7	7.2	9.2	6.4	6.1	7.3	6.9	5.3	10.2	5.3	8.1	8.8	9.7	17.2	7.1	7.9	5.2	8.7	7.7	3.0	3.4	8.5	5.4	9.6	11.8	9.3	7.2	13.8	5.9	10.1	10.6	28.5	8.8	6.2	5.1	21.2	7.4	5.1	8.0	5.8	9.6	8.1	6.5	14.1	7.8	39.8	12.1	14.3	6.6	3.3	3.9	9.6	15.1	7.1	9.2	7.6	15.4	9.0	7.8	4.6	6.0	8.7	6.3	2.5	7.8	7.5	8.4	5.2	8.4	7.3	7.2	5.9	6.5	7.4	1.8	13.1	4.0	4.6	9.2	5.5	13.2	13.6	14.3	16.8	12.8	19.8	17.0	10.8	16.2	15.6	3.0	6.7	12.0	8.7	6.6	5.4	16.2	7.6	1.4	5.7	14.0	2.0	10.4	33.2	10.5	7.6	8.2	3.3	0.0	13.2	18.4	7.7	13.3	8.1	4.2	12.0	4.8	0.0	10.4	9.5	11.5	8.1	7.2	10.1	9.0	6.2	6.0	10.4	9.1	11.0	11.2	7.2	12.9	11.3	20.6	28.7	7.9	8.4	4.3	8.8	8.7
